© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 12, 2013
Over 10 years, lifestyle intervention and metformin were cost-effective or cost saving compared with placebo.
Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis
Karan Lal, DO: Relationship Between Psoriasis and the Skin, Gut Microbiome
Karan Lal, DO: Psoriasis Treatment Advances, Spesolimab for Generalized Pustular Psoriasis